logo

Prostate cancer screening

What is the best treatment option for men with localised prostate cancer?

The management of clinically localised prostate cancer diagnosed after a PSA test remains controversial. Active surveillance is an option that can help ameliorate the negative effects of over-treatment of PSA-detected prostate cancer. The longer term outcomes of this approach compared … Continue reading

Posted in Clinical management, Men's health, Prostate cancer, Prostate cancer screening, Research and Evaluation |

Trends in prostate cancer care in Australia

Prostate cancer care has changed in recent years out of concern for over-diagnosis and over-treatment. However, many patients continue to undergo some form of curative treatment, and there is a perception among clinicians that more aggressive treatments are being favoured. … Continue reading

Posted in Clinical management, Knowledge exchange, Prostate cancer, Prostate cancer screening |

Australian clinical guidelines for prostate cancer testing released

The Prostate Cancer Foundation of Australia and Cancer Council Australia along with input from an expert advisory panel, which included Andrology Australia’s Director Prof Rob McLachlan, have developed national evidence-based clinical practice guidelines on PSA testing and early management of … Continue reading

Posted in Knowledge exchange, Prostate cancer, Prostate cancer screening |

Making decisions about the PSA test

The doctor says it’s time for you to have a PSA test. But what is the PSA test exactly?

Posted in Middle-aged and older males, Prostate cancer, Prostate cancer screening, Prostate disease | Tagged , , ,

Improving decisions about PSA testing

A recent study found that viewing a video-format decision aid reduced men’s interest in PSA screening, primarily those who were undecided prior to viewing the aid and more than half wanted to speak to their doctor about their decision.

Posted in Prostate cancer, Prostate cancer screening, Prostate disease |

Acceptance of over-detection in cancer screening

A study recently published in the BMJ examined the question, what level of over-detection people might find acceptable in cancer screening, given the expected benefit from screening and harms from over-detection?

Posted in Prostate cancer, Prostate cancer screening, Prostate disease, Research and Evaluation | Tagged

Testing the testosterone myths

In 'The Healthy Male', Summer 2014: Testosterone gets a lot of attention in the media and in the community these days, and not all of it is good. But how many of us really understand what testosterone is, what it does, and why it’s important?

Posted in Aboriginal and Torres Strait Islander males, Newsletter, Prostate cancer, Prostate cancer screening, Testosterone | Tagged , ,

PSA testing: getting to grips with the guidelines

Andrology Australia has attempted to review and summarise the current guidelines and position statements on PSA testing.

Posted in Prostate cancer, Prostate cancer screening, Prostate disease | Tagged ,

10 essential things health professionals should know about PSA testing

Andrology Australia recommends that a man considering PSA testing should be informed that there are uncertainties about treatment options in prostate cancer, that there are both potential gains and risks from PSA testing, and that an abnormal PSA result must be confirmed by further testing.

Posted in Primary health care, Prostate cancer, Prostate cancer screening, Prostate disease | Tagged

Biomarkers for predicting prostate cancer deaths in localised disease

Research findings show that biomarkers may help to improve prognostic models for localised prostate cancer.

Posted in Prostate cancer, Prostate cancer screening, Prostate disease, Research and Evaluation | Tagged
Website by Essendon Creative